Questions About Swine Flu Vaccine Productions
To discuss and make strong decisions to fight the widespread Swine Flu, the World Health Organization set a meeting with the vaccine manufacturers together with other health experts to stop the Swine Flu Outbreak. Different Pharmaceutical companies are making a Swine Flu vaccine — but as the virus may alter, there are questions formed:
How much should they have to produce? How will the government distribute the vaccines to the infected areas? Who should get it, babies, youngsters, pregnant women, seniors?
Most flu vaccine companies mentioned that they can only make one vaccine at a time: either seasonal flu vaccine or pandemic vaccine. Production takes months and it is impossible to switch halfway through if health officials make a mistake. Vaccine makers can make limited amounts of both seasonal flu vaccine and pandemic vaccine — though not at the same time — but they cannot make massive quantities of both because that exceeds manufacturing capacity.
Even if we are in the modern era, still the health officials have a big problem to solve the spreading of deadly swine flu is whether they will need more seasonal flu vaccine or swine flu vaccine. Scientists are not sure the effectiveness of a vaccine, if the swine flu will transmute. Only two billion doses of swine flu vaccine could be produced annually based on the estimation of World Health Organization officials, though the first batches wouldn’t be available for four to six months.
A “seed stock” to make the vaccine, which should be ready and it will be distributed to manufacturers worldwide so they can start producing the vaccine is now on the go as the U.S. Centers for Disease Control and Prevention works on. After the vaccine manufacturers get the seed stock, they won’t know how many doses of vaccine they can make or how long that would take.
Including vaccine producer, GlaxoSmithKline PLC, the World Health Organization is under negotiation process to save some of their swine flu vaccine for poorer nations. A couple of years ago members of the rich nations like United States, Switzerland, France, Denmark, Canada and Britain signed deals with the vaccine makers to guarantee them pandemic vaccines as soon as they’re available.
Cipla (The pharmaceuticals giant in India) instructed by the World Health Organization to make a generic version of Tamiflu antiviral drug. Tamiflu also known as oseltamivir, one of the two antiviral drugs to treat the Swine Flu. Then WHO said Cipla’s generic version was more effective than the original made by Swiss firm Roche Holding AG and would hopefully make the drug more accessible to the third world countries. As we all know that Indian pharmaceuticals produce drugs in very affordable prices.
Related posts:
